PF-114
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-114, covering 2020-02-17 to 2020-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene [Phase 1, Phase 2]